Dong Kook Pharmaceutical Co., Ltd. Reports Larger Cosmetics Contribution - report

Dong Kook Pharmaceutical Co., Ltd. (086450) recorded a 40.80% first-half revenue share from cosmetics and other pharmaceuticals, Dailian reported Sunday. The share rose 32.53 percentage points from the year the company entered cosmetics.

The company began its cosmetics business in 2015 and sells skincare products under the Centellian24 brand. It has expanded distribution beyond online platforms to physical stores in North America and Japan, according to the report.

The company's retail channels include Ulta Beauty and Loft alongside online platforms such as TikTok Shop and Amazon. The company's market capitalisation was ₩1 trillion at Friday's close.

Sources

  1. Dailian
Written from the filing or the Korean-language report it cites, not translated from it. Figures against this company's own statements are computed from DART data on kstock. kstock does not issue buy, sell or hold ratings and this is not investment advice.

One Korean filing a day, in English.

kstock reads DART every morning and writes up what moved — the contract, the buyback, the number that does not add up. The daily post and a Saturday roundup, by email.

Free. Unsubscribe anytime. Sent by Substack · Privacy